Top Markets
Coin of the day
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
Rankning i aktier #41304
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
Aktiekurs
$0.0003
Senast synkroniserad: 2023-06-13
Marknadsvärde
$28.14K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Neuropathix, Inc. (NPTX)

Kategori

Historik för aktiesplit för Neuropathix, Inc. (NPTX)
Aktien Neuropathix, Inc. (symbol: NPTX) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 13, 2026.
En NPTX-aktie köpt före Aug 13, 2026 motsvarar nu 0 NPTX-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE